Letter: risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications-reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study

PREPARE-IBD Study Group; Christopher A Lamb; Shaji Sebastian; Alexandra J Kent; Jonathan P Segal; Haidee A Gonzalez; Matthew J Brookes; Shameer J Mehta; Sreedhar Subramanian; Neeraj Bhala; Lucy C Hicks; Thomas E Conley; Kamal V Patel; Gareth J Walker; Nicholas A Kennedy

doi:10.1111/apt.16349

Letter: risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications-reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study

PREPARE-IBD Study Group, Christopher A Lamb, Shaji Sebastian, Alexandra J Kent, Jonathan P Segal, Haidee A Gonzalez, Matthew J Brookes, Shameer J Mehta, Sreedhar Subramanian, Neeraj Bhala, Lucy C Hicks, Thomas E Conley, Kamal V Patel, Gareth J Walker, Nicholas A Kennedy

Research output: Contribution to journal › Letter › peer-review

Abstract

LINKED CONTENT This article is linked to Taxonera et al paper. To view this article, visit https://doi.org/10.1111/apt.15804

Original language	English
Pages (from-to)	1236-1240
Number of pages	5
Journal	Alimentary Pharmacology and Therapeutics
Volume	53
Issue number	11
Early online date	7 May 2021
DOIs	https://doi.org/10.1111/apt.16349
Publication status	Published - Jun 2021

Keywords / Materials (for Non-textual outputs)

COVID-19
Cohort Studies
Humans
Inflammatory Bowel Diseases/complications
SARS-CoV-2
United Kingdom/epidemiology

Access to Document

10.1111/apt.16349

https://onlinelibrary.wiley.com/doi/10.1111/apt.16349

Cite this

PREPARE-IBD Study Group, Lamb, C. A., Sebastian, S., Kent, A. J., Segal, J. P., Gonzalez, H. A., Brookes, M. J., Mehta, S. J., Subramanian, S., Bhala, N., Hicks, L. C., Conley, T. E., Patel, K. V., Walker, G. J., & Kennedy, N. A. (2021). Letter: risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications-reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study. Alimentary Pharmacology and Therapeutics, 53(11), 1236-1240. https://doi.org/10.1111/apt.16349

@article{b115b151b76a4c0c9e556f31b5f462dd,

title = "Letter: risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications-reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study",

abstract = "LINKED CONTENT This article is linked to Taxonera et al paper. To view this article, visit https://doi.org/10.1111/apt.15804",

keywords = "COVID-19, Cohort Studies, Humans, Inflammatory Bowel Diseases/complications, SARS-CoV-2, United Kingdom/epidemiology",

author = "\{PREPARE-IBD Study Group\} and Lamb, \{Christopher A\} and Shaji Sebastian and Kent, \{Alexandra J\} and Segal, \{Jonathan P\} and Gonzalez, \{Haidee A\} and Brookes, \{Matthew J\} and Mehta, \{Shameer J\} and Sreedhar Subramanian and Neeraj Bhala and Hicks, \{Lucy C\} and Conley, \{Thomas E\} and Patel, \{Kamal V\} and Walker, \{Gareth J\} and Kennedy, \{Nicholas A\} and Shahida Din",

year = "2021",

month = jun,

doi = "10.1111/apt.16349",

language = "English",

volume = "53",

pages = "1236--1240",

journal = "Alimentary Pharmacology and Therapeutics",

issn = "0269-2813",

publisher = "Wiley",

number = "11",

}

PREPARE-IBD Study Group, Lamb, CA, Sebastian, S, Kent, AJ, Segal, JP, Gonzalez, HA, Brookes, MJ, Mehta, SJ, Subramanian, S, Bhala, N, Hicks, LC, Conley, TE, Patel, KV, Walker, GJ & Kennedy, NA 2021, 'Letter: risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications-reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study', Alimentary Pharmacology and Therapeutics, vol. 53, no. 11, pp. 1236-1240. https://doi.org/10.1111/apt.16349

Letter: risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications-reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study. / PREPARE-IBD Study Group; Lamb, Christopher A; Sebastian, Shaji et al.
In: Alimentary Pharmacology and Therapeutics, Vol. 53, No. 11, 06.2021, p. 1236-1240.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Letter

T2 - risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications-reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study

AU - PREPARE-IBD Study Group

AU - Lamb, Christopher A

AU - Sebastian, Shaji

AU - Kent, Alexandra J

AU - Segal, Jonathan P

AU - Gonzalez, Haidee A

AU - Brookes, Matthew J

AU - Mehta, Shameer J

AU - Subramanian, Sreedhar

AU - Bhala, Neeraj

AU - Hicks, Lucy C

AU - Conley, Thomas E

AU - Patel, Kamal V

AU - Walker, Gareth J

AU - Kennedy, Nicholas A

AU - Din, Shahida

PY - 2021/6

Y1 - 2021/6

N2 - LINKED CONTENT This article is linked to Taxonera et al paper. To view this article, visit https://doi.org/10.1111/apt.15804

AB - LINKED CONTENT This article is linked to Taxonera et al paper. To view this article, visit https://doi.org/10.1111/apt.15804

KW - COVID-19

KW - Cohort Studies

KW - Humans

KW - Inflammatory Bowel Diseases/complications

KW - SARS-CoV-2

KW - United Kingdom/epidemiology

U2 - 10.1111/apt.16349

DO - 10.1111/apt.16349

M3 - Letter

C2 - 33961708

SN - 0269-2813

VL - 53

SP - 1236

EP - 1240

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

IS - 11

ER -

PREPARE-IBD Study Group, Lamb CA, Sebastian S, Kent AJ, Segal JP, Gonzalez HA et al. Letter: risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications-reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study. Alimentary Pharmacology and Therapeutics. 2021 Jun;53(11):1236-1240. Epub 2021 May 7. doi: 10.1111/apt.16349

Letter: risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications-reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study

Abstract

Keywords / Materials (for Non-textual outputs)

Access to Document

Fingerprint

Cite this